NEUWAY Pharma GmbH

NEUWAY Pharma GmbH, Bonn, is committed to bringing novel class of biotherapeutics applying its proprietary EnPC® technology with a focus to treat CNS disorders. 

In addition to advancing its proprietary CNS pipeline, the company aims to be a partner of choice in particular for macromolecules drug developers (nucleic acids, proteins, small molecules) stymied by the hurdles of delivering these and other drug modalities into target tissues.

Operating as a drug developer and a delivery expert, NEUWAY will demonstrate the value of its technology through its internal orphan neurological disease pipeline and partnered programs.